Galena Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 95   

Articles published

GALE 1.71 +0.10 (6.21%)
price chart
Galena Biopharma Launches Zuplenz Oral Soluble Film
Galena Biopharma, Inc. (NASDAQ: GALE) today announced the product launch for Zuplenz´┐Ż (ondansetron) Oral Soluble Film in the United States.
Stock Update (NASDAQ:GALE) Galena Biopharma Inc Launches Zuplenz(R) Oral ...  Smarter Analyst
Galena Biopharma Launches Zuplenz(R) (ondansetron) Oral Soluble Film  GlobeNewswire (press release)
Can Galena Biopharma, Inc. (NASDAQ:GALE) Keep Up with Analyst Expectations?
Galena Biopharma, Inc. (NASDAQ:GALE) reported an earnings surprise of 0% when the company last reported earnings for the period ending on 2015-03-31.
Galena Biopharma, Inc. (NASDAQ:GALE) Short Interest Update  Money Flow Index
Galena Biopharma to Report Second Quarter Financial Results on Thursday ...  PharmiWeb.com (press release)
Biotech Stocks Worth Chasing – XOMA Corp (NASDAQ:XOMA), Galena Biopharma Inc ...
Galena Biopharma Inc (NASDAQ:GALE) advanced +6.62% to finish last trading session at $1.61. The company, on July 28, 2015, declared that the Company will report its second quarter 2015 financial results on Thursday, August 6, 2015 after the close of ...
Galena Biopharma Inc. (GALE) Drops 6.21% on July 27
Galena Biopharma Inc. (GALE) was one of the Russell 2000's biggest losers for Monday July 27 as the stock slid 6.21% to $1.51, a loss of $-0.1 per share.
Why Shares of Galena Biopharma, Inc. Spiked Today
What: Shares of Galena Biopharma (NASDAQ:GALE) climbed by over 12% on exceptional volume today after the company announced the publication of two abstracts for the upcoming American Society of Clinical Oncology, or ASCO, meeting being held May ...
Galena Biopharma Inc (GALE)'s Bullish Stance Reiterated at Maxim Ahead ...  Smarter Analyst
Galena Biopharma Announces Publication of Two Abstracts at the 2015 American ...  MarketWatch
Analyst Rating Update on Galena Biopharma, Inc.
As many as 6 brokerage firms have rated Galena Biopharma (NASDAQ:GALE) at 2.17. Research Analysts at Zacks have ranked the company at 2, suggesting the traders with a rating of buy for the short term.
Earnings Surprise in Focus: Galena Biopharma, Inc. (NASDAQ:GALE)  Investor Newswire
Biotech Stocks you should dump - Galena Biopharma Inc (NASDAQ:GALE), Vertex ...  Wall Street Observer
Galena Biopharma, Inc. (NASDAQ:GALE) Analyst Rating Update
Galena Biopharma (NASDAQ:GALE) has received a buy rating for the short term, according to the rank of 2 from research firm, Zacks.
Biotech Stocks leaving investors heartbroken - Galena Biopharma Inc (NASDAQ ...  Wall Street Observer
Galena Biopharma Receives Average Recommendation of "Buy" from ...  sleekmoney
Morning Buzz - C&J Energy Services, Ltd. (CJES), Galena Biopharma Inc (GALE ...
Galena Biopharma Inc (NASDAQ:GALE)remained and is at $1.51. The total traded volume was 578,510 shares and market capitalization arrived at $244.19M.
Short Interest Update of Galena Biopharma, Inc. (NASDAQ:GALE)
Galena Biopharma, Inc. (NASDAQ:GALE), A increase of 1,060,990 shares or 5.5% was observed in the short interest of Galena Biopharma, Inc. The interest on June 30,2015 came in at 20,257,037 shares and as per the average daily trading of 2,497,966 ...
Healthcare Sector Movers: Galena Biopharma, Inc. (GALE), Sunesis ...  WallStreet Scope
Micro Cap Stocks Watch List - Galena Biopharma (GALE), KaloBios ...  Techsonian (press release)
Watch List -JinkoSolar Holding Co., Ltd. (JKS),StemCellsInc (STEM), Galena ...
Watch List -JinkoSolar Holding Co., Ltd. (JKS),StemCellsInc (STEM), Galena Biopharma Inc (GALE),GrubHubInc (GRUB). By incredible stockalerts; • July 27, 2015.